EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Extracellular vesicle-encapsulated CC16 as novel nanotherapeutics for treatment of acute lung injury

Yohan Han, Yin Zhu, Sultan Almuntashiri, Xiaoyun Wang, Payaningal R Somanath, Caroline A Owen, Duo Zhang

Molecular Therapy · 2023-05 · 31 (5) · 1346-1364

DOI: 10.1016/j.ymthe.2023.01.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2023-05. Verfasst von Yohan Han und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia and Charlie Norwood VA Medical Center, Augusta, GA 30912, USA. Hauptthemen laut MEDLINE: NF-kappa B, Acute Lung Injury. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lung injury (ALI) is still associated with high mortality. Growing evidence suggests that Club Cell Protein 16 (CC16) plays a protective role against ALI. However, the doses of recombinant CC16 (rCC16) used in preclinical studies are supraphysiological for clinical applications. Extracellular vesicles (EVs) are nanovesicles endogenously generated by mammalian cells. Our study demonstrated that CC16 is released via small EVs and EV-encapsulated CC16 (sEV-CC16) and has anti-inflammatory activities, which protect mice from lipopolysaccharide (LPS) or bacteria-induced ALI. Additionally, sEV-CC16 can activate the DNA damage repair signaling pathways. Consistent with this activity, we observed more severe DNA damage in lungs from Cc16 knockout (KO) than wild-type (WT) mice. Mechanistically, we elucidated that CC16 suppresses nuclear factor κB (NF-κB) signaling activation by binding to heat shock protein 60 (HSP60). We concluded that sEV-CC16 could be a potential therapeutic agent for ALI by inhibiting the inflammatory and DNA damage responses by reducing NF-κB signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BAcute Lung InjuryMiceAnimalsLungSignal TransductionAnti-Inflammatory AgentsLipopolysaccharidesMammals

Stichwörter der Autor:innen

DNA repairHSP60NF-κB signalingSCGB1A1acute respiratory distress syndromeinflammation

Substanzen

NF-kappa BAnti-Inflammatory AgentsLipopolysaccharides

Autor:innen und Institutionen

  • Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia and Charlie Norwood VA Medical Center, Augusta, GA 30912, USA.
  • Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia and Charlie Norwood VA Medical Center, Augusta, GA 30912, USA; Department of Clinical Pharmacy, College of Pharmacy, University of Hail,…
  • Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia and Charlie Norwood VA Medical Center, Augusta, GA 30912, USA; Vascular Biology Center, Augusta University, Augusta, GA 30912, USA; Geor…
  • Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia and Charlie Norwood VA Medical Center, Augusta, GA 30912, USA; Vascular Biology Center, Augusta University, Augusta, GA 30912, USA. Elec…

Förderung

  • NHLBI NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Han, Y., Zhu, Y., Almuntashiri, S., Wang, X., Somanath, P. R., Owen, C. A., & Zhang, D. (2023). Extracellular vesicle-encapsulated CC16 as novel nanotherapeutics for treatment of acute lung injury. Molecular Therapy, 31(5), 1346-1364. https://doi.org/10.1016/j.ymthe.2023.01.009

Vancouver

Han Y, Zhu Y, Almuntashiri S, Wang X, Somanath PR, Owen CA, et al. Extracellular vesicle-encapsulated CC16 as novel nanotherapeutics for treatment of acute lung injury. Molecular Therapy. 2023;31(5):1346-1364. doi:10.1016/j.ymthe.2023.01.009

BibTeX
@article{Han2023,
  author = {Han, Yohan and Zhu, Yin and Almuntashiri, Sultan and Wang, Xiaoyun and Somanath, Payaningal R and Owen, Caroline A and Zhang, Duo},
  title = {Extracellular vesicle-encapsulated CC16 as novel nanotherapeutics for treatment of acute lung injury},
  journal = {Molecular Therapy},
  year = {2023},
  volume = {31},
  number = {5},
  pages = {1346--1364},
  doi = {10.1016/j.ymthe.2023.01.009}
}
Kostenlos starten →